Big moves usually have a paper trail. These are the public sources we check every day, and why each one can move a stock.
| Source | What it can reveal |
|---|---|
| SAM.gov exclusions | A company or subsidiary suspended or debarred from federal contracts, and when it's cleared |
| Federal Register public inspection | Rules posted a business day before publication: export blacklists, tariffs, Medicare payments, FDA and FAA actions |
| Defense Department contract awards | Daily awards over $7.5 million, often before the company announces them |
| GAO bid protests | Challenges to major federal awards and their decisions |
| FDA | Warning letters, import alerts and recalls |
| ClinicalTrials.gov | Drug trials marked terminated or suspended |
| NHTSA | Vehicle defect investigations and recalls |
| State WARN notices | Large layoffs and plant closures, filed 60 days ahead |
| Justice Department and court dockets | Unsealed False Claims Act fraud cases and settlements |
| SEC Form 4 | Insider buying and selling by executives and directors |
| Congressional disclosures | Stock trades reported by members of Congress under the STOCK Act |
After the close we take the day's largest moves among companies worth more than $2 billion, find the catalyst, and go a level deeper: what in the guidance spooked investors, what the drug data showed, which peers moved in sympathy. Every story lists its sources and a confidence rating. When we can't verify a reason, we say so.